Viemed Healthcare, Inc. (VMD) shareholders
Close on Nov 13, 2026Market cap $349.27MP/E 24.1Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Casey Hoyt Joint filing with Elizabeth Rose Homes LLC (5.20%) | 3,116,189 | 8.00% | 13G (passive) amendment | Dec 31, 2023 |
| Kissel Edward Urban Joint filing with Forager Capital Management, LLC (7.20%), Forager Fund, L.P. (7.20%) and 1 more | 2,736,472 | 7.20% | 13G (passive) amendment | Sep 30, 2025 |
| Thrivent Financial For Lutherans | 2,705,000 | 6.80% | 13G (passive) amendment | Mar 31, 2025 |
| BlackRock Portfolio Management LLC | 2,540,114 | 6.40% | 13G (passive) | Jun 30, 2025 |
| Michael Moore | 2,294,018 | 5.90% | 13D (active) amendment | Sep 24, 2026 |
| BlackRock, Inc. | 2,278,664 | 5.80% | 13G (passive) amendment | Mar 31, 2025 |
| MacArthur Robert Symmes Joint filing with Forager Capital Management, LLC (5.50%), Forager Fund, L.P. (5.50%) and 1 more | 2,186,472 | 5.50% | 13G (passive) | Jun 24, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of VMD | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4,788,307 | 12.57% | $54.59M | +165,745 | 0.00% |
| Forager Capital Management, LLC | 2,141,184 | 5.62% | $24.41M | −684,687 | 9.18% |
| Vanguard Capital Management LLC | 1,321,676 | 3.47% | $15.07M | +18,292 | 0.00% |
| Nantahala Capital Management, LLC | 1,264,890 | 3.32% | $14.42M | +381,107 | 0.24% |
| Goldman Sachs Group Inc | 1,222,534 | 3.21% | $13.94M | −199,100 | 0.00% |
| First Eagle Investment Management, LLC | 1,070,314 | 2.81% | $12.20M | +540,657 | 0.01% |
| Ameriprise Financial Inc | 1,006,195 | 2.64% | $11.47M | +107,876 | 0.00% |
| Geode Capital Management, LLC | 973,744 | 2.56% | $11.10M | +194,222 | 0.00% |
| Raffles Associates LP | 807,382 | 2.12% | $9.20M | +393,691 | 4.04% |
| Arrowstreet Capital, Limited Partnership | 786,269 | 2.06% | $8.96M | +75,083 | 0.00% |
| State Street Corp | 762,097 | 2.00% | $8.69M | +19,138 | 0.00% |
| Panagora Asset Management Inc | 538,625 | 1.41% | $6.14M | +66,528 | 0.02% |
| Punch & Associates Investment Management, Inc. | 533,466 | 1.40% | $6.08M | −3,895 | 0.30% |
| Two Sigma Investments, LP | 438,851 | 1.15% | $5.00M | +25,457 | 0.00% |
| Renaissance Technologies LLC | 425,900 | 1.12% | $4.86M | −16,300 | 0.01% |
| Acadian Asset Management LLC | 398,586 | 1.05% | $4.54M | +233,299 | 0.01% |
| Creative Planning | 360,356 | 0.95% | $4.11M | +139,954 | 0.00% |
| Tocqueville Asset Management L.P. | 342,100 | 0.90% | $3.90M | −130,000 | 0.05% |
| Martin & Co Inc /Tn/ | 340,771 | 0.89% | $3.88M | +67,770 | 0.61% |
| Bard Associates Inc | 339,672 | 0.89% | $3.87M | −269 | 0.86% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 167 | 27M | 71.3% | 29 / 72 | 34 / 11 | 4M | 2M |
| Q1 2026 | 150 | 25M | 65.3% | 32 / 54 | 41 / 12 | 5M | 2M |
| Q4 2025 | 132 | 24M | 63.0% | 20 / 44 | 42 / 14 | 2M | 2M |
| Q3 2025 | 131 | 25M | 64.6% | 13 / 44 | 46 / 9 | 3M | 4M |
| Q2 2025 | 127 | 26M | 67.3% | 11 / 61 | 35 / 22 | 3M | 2M |
| Q1 2025 | 139 | 25M | 65.3% | 11 / 53 | 42 / 10 | 2M | 2M |
| Q4 2024 | 141 | 25M | 66.4% | 30 / 45 | 28 / 8 | 2M | 2M |
| Q3 2024 | 121 | 25M | 66.4% | 22 / 40 | 26 / 15 | 6M | 4M |
| Q2 2024 | 116 | 27M | 70.6% | 19 / 54 | 28 / 15 | 4M | 3M |
| Q1 2024 | 112 | 25M | 66.7% | 21 / 36 | 28 / 13 | 4M | 4M |
| Q4 2023 | 104 | 25M | 66.8% | 12 / 33 | 35 / 20 | 4M | 2M |
| Q3 2023 | 112 | 24M | 61.8% | 20 / 38 | 33 / 10 | 2M | 2M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
135 funds held VMD in Q2 2026, 43% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of VMD | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 912,713 | 2.40% | $10.40M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 870,045 | 2.28% | $9.92M | 0.01% | Jun 30, 2026 |
| Columbia Small Cap Value Discovery Fund | 566,630 | 1.49% | $6.61M | 0.26% | Jul 31, 2026 |
| BlackRock Advantage Small Cap Core Fund | 485,288 | 1.27% | $4.78M | 0.09% | May 29, 2026 |
| First Eagle Small Cap Opportunity Fund | 467,300 | 1.23% | $5.45M | 0.19% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 373,459 | 0.98% | $4.26M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 372,227 | 0.98% | $4.34M | 0.01% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 319,961 | 0.84% | $3.65M | 0.02% | Jun 30, 2026 |
| Vanguard Russell 2000 Index Fund | 171,949 | 0.45% | $1.69M | 0.01% | May 31, 2026 |
| Fidelity Extended Market Index Fund | 170,736 | 0.45% | $1.68M | 0.00% | May 31, 2026 |
| BlackRock Advantage Small Cap Growth Fund | 124,615 | 0.33% | $1.42M | 0.17% | Jun 30, 2026 |
| iShares Micro-Cap ETF | 114,129 | 0.30% | $1.30M | 0.09% | Jun 30, 2026 |
| First Trust Dow Jones Select MicroCap Index Fund | 110,694 | 0.29% | $1.26M | 0.48% | Jun 30, 2026 |
| Columbia Variable Portfolio - Small Cap Value Discovery Fund | 102,520 | 0.27% | $1.17M | 0.26% | Jun 30, 2026 |
| Fidelity SAI Small-Mid Cap Momentum Index Fund | 101,049 | 0.27% | $1.18M | 0.03% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| William Frazier | Chief Medical Officer, Director | 83,214 | 0.22% | Jun 26, 2026 |
| Casey Hoyt | Chief Executive Officer, Director | 2,349,320 | 6.17% | Feb 2, 2026 |
| William Todd Zehnder | Chief Operating Officer, Director | 401,677 | 1.05% | Feb 2, 2026 |
| Michael Moore | President | 1,774,902 | 4.66% | Mar 20, 2026 |
| Jeremy Trahan | General Counsel | 49,431 | 0.13% | Feb 2, 2026 |
| Jerome Cambre | Vice President of Sales | 106,443 | 0.28% | Feb 2, 2026 |
| Trae Fitzgerald | Chief Financial Officer | 105,638 | 0.28% | Feb 2, 2026 |
| Nitin Kaushal | Director | 161,361 | 0.42% | Aug 19, 2026 |
| Sabrina Heltz | Director | 82,520 | 0.22% | Aug 19, 2026 |
| Randy E. Dobbs | Director | 142,253 | 0.37% | Aug 19, 2026 |
| Timothy Smokoff | Director | 94,304 | 0.25% | Aug 19, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Randy E. Dobbs Director | Aug 19, 2026 | Returned to company | −4,191 | $8.94 | $37.47K | 142,253 |
| Randy E. Dobbs Director | Aug 19, 2026 | Option exercise | +4,191 | – | – | 146,444 |
| Randy E. Dobbs Director | Aug 19, 2026 | Option exercise | +16,763 | – | – | 142,253 |
| Timothy Smokoff Director | Aug 19, 2026 | Option exercise | +3,757 | – | – | 94,304 |
| Timothy Smokoff Director | Aug 19, 2026 | Returned to company | −3,757 | $8.94 | $33.59K | 90,547 |
| Timothy Smokoff Director | Aug 19, 2026 | Option exercise | +15,029 | – | – | 90,547 |
| Nitin Kaushal Director | Aug 19, 2026 | Option exercise | +18,786 | – | – | 161,361 |
| Sabrina Heltz Director | Aug 19, 2026 | Returned to company | −3,757 | $8.94 | $33.59K | 82,520 |
| Sabrina Heltz Director | Aug 19, 2026 | Option exercise | +3,757 | – | – | 86,277 |
| Sabrina Heltz Director | Aug 19, 2026 | Option exercise | +15,029 | – | – | 82,520 |
| William Frazier Chief Medical Officer, Director | Jun 25, 2026 | Option exercise | +10,000 | $1.81 | $18.10K | 83,214 |
| William Frazier Chief Medical Officer, Director | Jun 25, 2026 | Sale | −10,000 | $11.72 | $117.20K | 73,214 |
| Timothy Smokoff Director | Jun 24, 2026 | Sale | −5,000 | $11.53 | $57.65K | 80,518 |
| Timothy Smokoff Director | Jun 24, 2026 | Sale | −1,636 | $11.48 | $18.78K | 93,882 |
| Timothy Smokoff Director | Jun 24, 2026 | Sale | −5,000 | $11.41 | $57.05K | 75,518 |
| Timothy Smokoff Director | Jun 24, 2026 | Sale | −5,000 | $11.56 | $57.80K | 85,518 |
| Timothy Smokoff Director | Jun 24, 2026 | Sale | −3,364 | $11.50 | $38.69K | 90,518 |
| Michael Moore President | Mar 20, 2026 | Sale | −65,000 | $8.77 | $570.05K | 1,585,812 |
| Michael Moore President | Mar 19, 2026 | Sale | −40,232 | $9.21 | $370.54K | 1,650,812 |
| Michael Moore President | Mar 18, 2026 | Sale | −31,570 | $9.42 | $297.39K | 1,691,044 |
| Jerome Cambre Vice President of Sales | Jan 29, 2026 | Option exercise | +8,619 | – | – | 106,443 |
| Jerome Cambre Vice President of Sales | Jan 29, 2026 | Tax withholding | −2,355 | $7.48 | $17.62K | 104,088 |
| Jerome Cambre Vice President of Sales | Jan 29, 2026 | Option exercise | +2,873 | – | – | 106,961 |
| Jerome Cambre Vice President of Sales | Jan 29, 2026 | Returned to company | −2,873 | $7.48 | $21.49K | 104,088 |
| Jeremy Trahan General Counsel | Jan 29, 2026 | Option exercise | +10,774 | – | – | 49,431 |
| Jeremy Trahan General Counsel | Jan 29, 2026 | Tax withholding | −2,939 | $7.48 | $21.98K | 46,492 |
| Jeremy Trahan General Counsel | Jan 29, 2026 | Option exercise | +3,591 | – | – | 50,083 |
| Jeremy Trahan General Counsel | Jan 29, 2026 | Returned to company | −3,591 | $7.48 | $26.86K | 46,492 |
| Michael Moore President | Jan 29, 2026 | Tax withholding | −7,342 | $7.48 | $54.92K | 189,090 |
| Michael Moore President | Jan 29, 2026 | Option exercise | +26,842 | – | – | 196,432 |
| Michael Moore President | Jan 29, 2026 | Returned to company | −8,947 | $7.48 | $66.92K | 189,090 |
| Michael Moore President | Jan 29, 2026 | Option exercise | +8,947 | – | – | 198,037 |
| Trae Fitzgerald Chief Financial Officer | Jan 29, 2026 | Returned to company | −3,265 | $7.48 | $24.42K | 105,638 |
| Trae Fitzgerald Chief Financial Officer | Jan 29, 2026 | Option exercise | +9,794 | – | – | 108,317 |
| Trae Fitzgerald Chief Financial Officer | Jan 29, 2026 | Tax withholding | −2,679 | $7.48 | $20.04K | 105,638 |
| Trae Fitzgerald Chief Financial Officer | Jan 29, 2026 | Option exercise | +3,265 | – | – | 108,903 |
| William Todd Zehnder Chief Operating Officer, Director | Jan 29, 2026 | Option exercise | +26,842 | – | – | 401,677 |
| William Todd Zehnder Chief Operating Officer, Director | Jan 29, 2026 | Tax withholding | −11,368 | $7.48 | $85.03K | 390,309 |
| William Todd Zehnder Chief Operating Officer, Director | Jan 29, 2026 | Option exercise | +8,948 | – | – | 399,257 |
| William Todd Zehnder Chief Operating Officer, Director | Jan 29, 2026 | Returned to company | −8,948 | $7.48 | $66.93K | 390,309 |
| William Frazier Chief Medical Officer, Director | Jan 29, 2026 | Tax withholding | −802 | $7.48 | $6.00K | 73,214 |
| William Frazier Chief Medical Officer, Director | Jan 29, 2026 | Option exercise | +778 | – | – | 73,992 |
| William Frazier Chief Medical Officer, Director | Jan 29, 2026 | Returned to company | −778 | $7.48 | $5.82K | 73,214 |
| William Frazier Chief Medical Officer, Director | Jan 29, 2026 | Option exercise | +2,334 | – | – | 74,016 |
| Casey Hoyt Chief Executive Officer, Director | Jan 29, 2026 | Option exercise | +39,795 | – | – | 364,377 |
| Casey Hoyt Chief Executive Officer, Director | Jan 29, 2026 | Tax withholding | −13,913 | $7.48 | $104.07K | 350,464 |
| Casey Hoyt Chief Executive Officer, Director | Jan 29, 2026 | Option exercise | +13,265 | – | – | 363,729 |
| Casey Hoyt Chief Executive Officer, Director | Jan 29, 2026 | Returned to company | −13,265 | $7.48 | $99.22K | 350,464 |
| Jerome Cambre Vice President of Sales | Jan 21, 2026 | Option exercise | +11,719 | – | – | 101,651 |
| Jerome Cambre Vice President of Sales | Jan 21, 2026 | Tax withholding | −3,827 | $7.49 | $28.66K | 97,824 |
| Jerome Cambre Vice President of Sales | Jan 21, 2026 | Returned to company | −2,930 | $7.49 | $21.95K | 97,824 |
| Jerome Cambre Vice President of Sales | Jan 21, 2026 | Option exercise | +2,930 | – | – | 100,754 |
| Casey Hoyt Chief Executive Officer, Director | Jan 21, 2026 | Option exercise | +12,400 | – | – | 336,982 |
| Casey Hoyt Chief Executive Officer, Director | Jan 21, 2026 | Tax withholding | −13,565 | $7.49 | $101.60K | 324,582 |
| Casey Hoyt Chief Executive Officer, Director | Jan 21, 2026 | Returned to company | −12,400 | $7.49 | $92.88K | 324,582 |
| Casey Hoyt Chief Executive Officer, Director | Jan 21, 2026 | Option exercise | +49,597 | – | – | 338,147 |
| Trae Fitzgerald Chief Financial Officer | Jan 21, 2026 | Tax withholding | −4,246 | $7.49 | $31.80K | 98,523 |
| Trae Fitzgerald Chief Financial Officer | Jan 21, 2026 | Option exercise | +13,317 | – | – | 102,769 |
| Trae Fitzgerald Chief Financial Officer | Jan 21, 2026 | Returned to company | −3,329 | $7.49 | $24.93K | 98,523 |
| Trae Fitzgerald Chief Financial Officer | Jan 21, 2026 | Option exercise | +3,329 | – | – | 101,852 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Viemed Healthcare's stock actually held short. Settlement fails (shares not delivered on time) peaked at 2,336 shares on Aug 28, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Moore Faster LLC Officer | Mar 20, 2026 | 65,000 | $570.12K | Mar 20, 2026 | Merger/Acquisition |
| Moore Faster LLC Officer | Mar 19, 2026 | 40,232 | $370.42K | Mar 19, 2026 | Merger/Acquisition |
| Moore Faster LLC Officer | Mar 18, 2026 | 31,570 | $297.35K | Mar 18, 2026 | Merger/Acquisition |
See a number that looks wrong?